SEARCH

SEARCH BY CITATION

References

  • Abbo A, Carmeli Y, Navon-Venezia S, Siegman-Igra Y & Schwaber MJ (2007) Impact of multi-drug-resistant Acinetobacter baumannii on clinical outcomes. Eur J Clin Microbiol Infect Dis 26: 793800.
  • Adams MD, Nickel GC, Bajaksouzian S, Lavender H, Murthy AR, Jacobs MR & Bonomo RA (2009) Resistance to colistin in Acinetobacter baumannii associated with mutations in the PmrAB two-component system. Antimicrob Agents Chemother 53: 36283634.
  • Albrecht MC, Griffith ME, Murray CK et al. (2006) Impact of Acinetobacter infection on the mortality of burn patients. J Am Coll Surg 203: 546550.
  • Anstey NM, Currie BJ & Withnall KM (1992) Community-acquired Acinetobacter pneumonia in the Northern Territory of Australia. Clin Infect Dis 14: 8391.
  • Anstey NM, Currie BJ, Hassell M, Palmer D, Dwyer B & Seifert H (2002) Community-acquired bacteremic Acinetobacter pneumonia in tropical Australia is caused by diverse strains of Acinetobacter baumannii, with carriage in the throat in at-risk groups. J Clin Microbiol 40: 685686.
  • Antunes LC, Imperi F, Carattoli A & Visca P (2011a) Deciphering the multifactorial nature of Acinetobacter baumannii pathogenicity. PLoS ONE 6: e22674.
  • Antunes LC, Imperi F, Towner KJ & Visca P (2011b) Genome-assisted identification of putative iron-utilization genes in Acinetobacter baumannii and their distribution among a genotypically diverse collection of clinical isolates. Res Microbiol 162: 279284.
  • Asensio A, Canton R, Vaque J, Calbo-Torrecillas F, Herruzo R, Arribas JL & Saenz MC (2008) Prevalence of infection by carbapenem-resistant Acinetobacter baumannii in Spain (1999–2005). Enferm Infecc Microbiol Clin 26: 199204.
  • Azoulay-Dupuis E, Bedos JP, Vallee E & Pocidalo JJ (1991) Comparative activity of fluorinated quinolones in acute and subacute Streptococcus pneumoniae pneumonia models: efficacy of temafloxacin. J Antimicrob Chemother 28(Suppl C): 4553.
  • Barker J & Maxted H (1975) Observations on the growth and movement of Acinetobacter on semi-solid media. J Med Microbiol 8: 443446.
  • Batson HC, Landy M & Brown M (1950) Determination of differences in virulence of strains of Salmonella typhosa; a comparison of methods. J Exp Med 91: 219229.
  • Beceiro A, Pérez A, Fernéndez-Cuenca F et al. (2009) Genetic variability among ampC genes from acinetobacter genomic species 3. Antimicrob Agents Chemother 53: 11771184.
  • Bernabeu-Wittel M, Pichardo C, Garcia-Curiel A, Pachón-Ibañez ME, Ibañez-Martinez J, Jimenez-Mejias ME & Pachón J (2005) Pharmacokinetic/pharmacodynamic assessment of the in-vivo efficacy of imipenem alone or in combination with amikacin for the treatment of experimental multiresistant Acinetobacter baumannii pneumonia. Clin Microbiol Infect 11: 319325.
  • Bhagan-Bruno S, Lather N & Fergus IV (2010) Acinetobacter endocarditis presenting as a large right atrial mass: an atypical presentation. Echocardiography 27: E39E42.
  • Borer A, Gilad J, Smolyakov R et al. (2005) Cell phones and Acinetobacter transmission. Emerg Infect Dis 11: 11601161.
  • Bouvet PJM & Grimont PAD (1986) Taxonomy of the genus Acinetobacter with the recognition of Acinetobacter baumannii sp. nov., Acinetobacter haemolyticus sp. nov., Acinetobacter johnsonii sp. nov., and Acinetobacter junii sp. nov. and emended descriptions of Acinetobacter calcoaceticus and Acinetobacter lwoffii. Int J Syst Bacteriol 36: 228240.
  • Brachelente C, Wiener D, Malik Y & Huessy D (2007) A case of necrotizing fasciitis with septic shock in a cat caused by Acinetobacter baumannii. Vet Dermatol 18: 432438.
  • Braunstein A, Papo N & Shai Y (2004) In vitro activity and potency of an intravenously injected antimicrobial peptide and its DL amino acid analog in mice infected with bacteria. Antimicrob Agents Chemother 48: 31273129.
  • Camarena L, Bruno V, Euskirchen G, Poggio S & Snyder M (2010) Molecular mechanisms of ethanol-induced pathogenesis revealed by RNA-sequencing. PLoS Pathog 6: e1000834.
  • Canvin JR, Marvin AP, Sivakumaran M, Paton JC, Boulnois GJ, Andrew PW & Mitchell TJ (1995) The role of pneumolysin and autolysin in the pathology of pneumonia and septicemia in mice infected with a type 2 pneumococcus. J Infect Dis 172: 119123.
  • Cascio A, Conti A, Sinardi L et al. (2010) Post-neurosurgical multidrug-resistant Acinetobacter baumannii meningitis successfully treated with intrathecal colistin. A new case and a systematic review of the literature. Int J Infect Dis 14: e572e579.
  • Chang WN, Lu CH, Huang CR & Chuang YC (2000) Community-acquired Acinetobacter meningitis in adults. Infection 28: 395397.
  • Charnot-Katsikas A, Dorafshar AH, Aycock JK, David MZ, Weber SG & Frank KM (2009) Two cases of necrotizing fasciitis due to Acinetobacter baumannii. J Clin Microbiol 47: 258263.
  • Chen MZ, Hsueh PR, Lee LN, Yu CJ, Yang PC & Luh KT (2001) Severe community-acquired pneumonia due to Acinetobacter baumannii. Chest 120: 10721077.
  • Chiang SR, Chuang YC, Tang HJ et al. (2009) Intratracheal colistin sulfate for BALB/c mice with early pneumonia caused by carbapenem-resistant Acinetobacter baumannii. Crit Care Med 37: 25902595.
  • Chim H, Tan BH & Song C (2007) Five-year review of infections in a burn intensive care unit: high incidence of Acinetobacter baumannii in a tropical climate. Burns 33: 10081014.
  • Choi CH, Lee EY, Lee YC et al. (2005) Outer membrane protein 38 of Acinetobacter baumannii localizes to the mitochondria and induces apoptosis of epithelial cells. Cell Microbiol 7: 11271138.
  • Choi CH, Lee JS, Lee YC, Park TI & Lee JC (2008) Acinetobacter baumannii invades epithelial cells and outer membrane protein A mediates interactions with epithelial cells. BMC Microbiol 8: 216.
  • Choi AH, Slamti L, Avci FY, Pier GB & Maira-Litran T (2009) The pgaABCD locus of Acinetobacter baumannii encodes the production of poly-beta-1-6-N-acetylglucosamine, which is critical for biofilm formation. J Bacteriol 191: 59535963.
  • Chopra I, Schofield C, Everett M et al. (2008) Treatment of health-care-associated infections caused by Gram-negative bacteria: a consensus statement. Lancet Infect Dis 8: 133139.
  • Cirioni O, Silvestri C, Ghiselli R et al. (2009) Therapeutic efficacy of buforin II and rifampin in a rat model of Acinetobacter baumannii sepsis. Crit Care Med 37: 14031407.
  • Cisneros JM, Reyes MJ, Pachón J et al. (1996) Bacteremia due to Acinetobacter baumannii: epidemiology, clinical findings, and prognostic features. Clin Infect Dis 22: 10261032.
  • Clemmer KM, Bonomo RA & Rather PN (2011) Genetic analysis of surface motility in Acinetobacter baumannii. Microbiology 157: 25342544.
  • Collinet-Adler S, Castro CA, Ledonio CG, Bechtold JE & Tsukayama DT (2010) Acinetobacter baumannii is not associated with osteomyelitis in a rat model: a pilot study. Clin Orthop Relat Res 469: 274282.
  • Corradino B, Toia F, di Lorenzo S, Cordova A & Moschella F (2010) A difficult case of necrotizing fasciitis caused by Acinetobacter baumannii. Int J Low Extrem Wounds 9: 152154.
  • Costerton JW, Stewart PS & Greenberg EP (1999) Bacterial biofilms: a common cause of persistent infections. Science 284: 13181322.
  • Crandon JL, Kim A & Nicolau DP (2009) Comparison of tigecycline penetration into the epithelial lining fluid of infected and uninfected murine lungs. J Antimicrob Chemother 64: 837839.
  • Crane DP, Gromov K, Li D et al. (2009) Efficacy of colistin-impregnated beads to prevent multidrug-resistant A. baumannii implant-associated osteomyelitis. J Orthop Res 27: 10081015.
  • Crnich CJ, Safdar N & Maki DG (2005) The role of the intensive care unit environment in the pathogenesis and prevention of ventilator-associated pneumonia. Respir Care 50: 813836; discussion 836–818.
  • Crosa JH & Walsh CT (2002) Genetics and assembly line enzymology of siderophore biosynthesis in bacteria. Microbiol Mol Biol Rev 66: 223249.
  • Crosa JH, Mey AR & Payne SM (2004) Iron Transport in Bacteria. ASM Press, Washington, DC.
  • Dai T, Tegos GP, Lu Z et al. (2009) Photodynamic therapy for Acinetobacter baumannii burn infections in mice. Antimicrob Agents Chemother 53: 39293934.
  • Dalhoff A, Frank G & Luckhaus G (1982) The granuloma pouch: an in vivo model for pharmacokinetic and chemotherapeutic investigations. I. Biochemical and histological characterization. Infection 10: 354360.
  • Dalhoff A, Frank G & Luckhaus G (1983) The granuloma pouch: an in vivo model for pharmacokinetic and chemotherapeutic investigations. II. Microbiological characterization. Infection 11: 4146.
  • Davis KA, Moran KA, McAllister CK & Gray PJ (2005) Multidrug-resistant Acinetobacter extremity infections in soldiers. Emerg Infect Dis 11: 12181224.
  • de Breij A, Gaddy J, van der Meer J et al. (2009) CsuA/BABCDE-dependent pili are not involved in the adherence of Acinetobacter baumannii ATCC19606(T) to human airway epithelial cells and their inflammatory response. Res Microbiol 160: 213218.
  • de Breij A, Dijkshoorn L, Lagendijk E et al. (2010) Do biofilm formation and interactions with human cells explain the clinical success of Acinetobacter baumannii? PLoS ONE 5: e10732.
  • DeLeon K, Balldin F, Watters C, Hamood A, Griswold J, Sreedharan S & Rumbaugh KP (2009) Gallium maltolate treatment eradicates Pseudomonas aeruginosa infection in thermally injured mice. Antimicrob Agents Chemother 53: 13311337.
  • Dijkshoorn L, Brouwer CP, Bogaards SJ, Nemec A, van den Broek PJ & Nibbering PH (2004) The synthetic N-terminal peptide of human lactoferrin, hLF(1-11), is highly effective against experimental infection caused by multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother 48: 49194921.
  • Dijkshoorn L, Nemec A & Seifert H (2007) An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat Rev Microbiol 5: 939951.
  • Doi Y, Onuoha EO, Adams-Haduch JM et al. (2010) Screening for Acinetobacter baumannii colonization by use of sponges. J Clin Microbiol 49: 154158.
  • Donlan RM & Costerton JW (2002) Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 15: 167193.
  • Dorsey CW, Tomaras AP, Connerly PL, Tolmasky ME, Crosa JH & Actis LA (2004) The siderophore-mediated iron acquisition systems of Acinetobacter baumannii ATCC 19606 and Vibrio anguillarum 775 are structurally and functionally related. Microbiology 150: 36573667.
  • Echenique JR, Arienti H, Tolmasky ME, Read R, Staneloni J, Crosa JH & Actis LA (1992) Characterization of a high-affinity iron transport system in Acinetobacter baumannii. J Bacteriol 174: 76707679.
  • Edwards J, Patel G & Wareham DW (2007) Low concentrations of commercial alcohol hand rubs facilitate growth of and secretion of extracellular proteins by multidrug-resistant strains of Acinetobacter baumannii. J Med Microbiol 56: 15951599.
  • Eijkelkamp BA, Hassan KA, Paulsen IT & Brown MH (2011) Investigation of the human pathogen Acinetobacter baumannii under iron limiting conditions. BMC Genomics 12: 126.
  • Ellis TN & Kuehn MJ (2010) Virulence and immunomodulatory roles of bacterial outer membrane vesicles. Microbiol Mol Biol Rev 74: 8194.
  • Erbay A, Idil A, Gozel MG, Mumcuoglu I & Balaban N (2009) Impact of early appropriate antimicrobial therapy on survival in Acinetobacter baumannii bloodstream infections. Int J Antimicrob Agents 34: 575579.
  • Esposito AL & Pennington JE (1984) Experimental pneumonia due to Haemophilus influenzae: observations on pathogenesis and treatment. J Infect Dis 149: 728734.
  • Eveillard M, Soltner C, Kempf M et al. (2010) The virulence variability of different Acinetobacter baumannii strains in experimental pneumonia. J Infect 60: 154161.
  • Fagon JY, Chastre J, Domart Y, Trouillet JL & Gibert C (1996) Mortality due to ventilator-associated pneumonia or colonization with Pseudomonas or Acinetobacter species: assessment by quantitative culture of samples obtained by a protected specimen brush. Clin Infect Dis 23: 538542.
  • Falagas ME & Rafailidis PI (2007) Attributable mortality of Acinetobacter baumannii: no longer a controversial issue. Crit Care 11: 134.
  • Falagas ME, Kopterides P & Siempos II (2006a) Attributable mortality of Acinetobacter baumannii infection among critically ill patients. Clin Infect Dis 43: 389; author reply 389–390.
  • Falagas ME, Kasiakou SK, Rafailidis PI, Zouglakis G & Morfou P (2006b) Comparison of mortality of patients with Acinetobacter baumannii bacteraemia receiving appropriate and inappropriate empirical therapy. J Antimicrob Chemother 57: 12511254.
  • Fetiye K, Karadenizli A, Okay E, Oz S, Budak F, Gundes S & Vahaboglu H (2004) Comparison in a rat thigh abscess model of imipenem, meropenem and cefoperazone-sulbactam against Acinetobacter baumannii strains in terms of bactericidal efficacy and resistance selection. Ann Clin Microbiol Antimicrob 3: 2.
  • Figueiredo S, Bonnin RA, Poirel L, Duranteau J & Nordmann P (2011) Identification of the naturally occurring genes encoding carbapenem-hydrolysing oxacillinases from Acinetobacter haemolyticus, Acinetobacter johnsonii, and Acinetobacter calcoaceticus. Clin Microbiol Infect in press.
  • Fishbain J & Peleg AY (2010) Treatment of Acinetobacter infections. Clin Infect Dis 51: 7984.
  • Fournier PE, Vallenet D, Barbe V et al. (2006) Comparative genomics of multidrug resistance in Acinetobacter baumannii. PLoS Genet 2: e7.
  • Fregolino E, Gargiulo V, Lanzetta R, Parrilli M, Holst O & Castro CD (2011) Identification and structural determination of the capsular polysaccharides from two Acinetobacter baumannii clinical isolates, MG1 and SMAL. Carbohydr Res 346: 973977.
  • Gaddy JA & Actis LA (2009) Regulation of Acinetobacter baumannii biofilm formation. Future Microbiol 4: 273278.
  • Gaddy JA, Tomaras AP & Actis LA (2009) The Acinetobacter baumannii 19606 OmpA protein plays a role in biofilm formation on abiotic surfaces and the interaction of this pathogen with eukaryotic cells. Infect Immun 77: 31503160.
  • Gaddy JA, Arivett BA, McConnell MJ, López-Rojas R, Pachón J & Actis LA (2012) Role of acinetobactin-mediated iron acquisition functions in the interaction of Acinetobacter baumannii ATCC 19606T with human lung epithelial cells, Galleria mellonella caterpillars and mice. Infect Immun 80: 10151024.
  • García-Garmendia JL, Ortiz-Leyba C, Garnacho-Montero J, Jiménez-Jimenez FJ, Monterrubio-Villar J & Gili-Miner M (1999) Mortality and the increase in length of stay attributable to the acquisition of Acinetobacter in critically ill patients. Crit Care Med 27: 17941799.
  • Garnacho J, Sole-Violan J, Sa-Borges M, Diaz E & Rello J (2003) Clinical impact of pneumonia caused by Acinetobacter baumannii in intubated patients: a matched cohort study. Crit Care Med 31: 24782482.
  • Garzoni C, Emonet S, Legout L, Benedict R, Hoffmeyer P, Bernard L & Garbino J (2005) Atypical infections in tsunami survivors. Emerg Infect Dis 11: 15911593.
  • Gaynes R & Edwards JR (2005) Overview of nosocomial infections caused by gram-negative bacilli. Clin Infect Dis 41: 848854.
  • González RH, Nusblat A & Nudel BC (2001) Detection and characterization of quorum sensing signal molecules in Acinetobacter strains. Microbiol Res 155: 271277.
  • González RH, Dijkshoorn L, Van den Barselaar M & Nudel C (2009) Quorum sensing signal profile of Acinetobacter strains from nosocomial and environmental sources. Rev Argent Microbiol 41: 7378.
  • Gordon NC & Wareham DW (2010) Multidrug-resistant Acinetobacter baumannii: mechanisms of virulence and resistance. Int J Antimicrob Agents 35: 219226.
  • Griffith ME, Ceremuga JM, Ellis MW, Guymon CH, Hospenthal DR & Murray CK (2006) Acinetobacter skin colonization of US Army Soldiers. Infect Control Hosp Epidemiol 27: 659661.
  • Henrichsen J (1975) The influence of changes in the environment on twitching motility. Acta Pathol Microbiol Scand B 83: 179186.
  • Henrichsen J (1984) Not gliding but twitching motility of Acinetobacter calcoaceticus. J Clin Pathol 37: 102103.
  • Henrichsen J & Blom J (1975) Correlation between twitching motility and possession of polar fimbriae in Acinetobacter calcoaceticus. Acta Pathol Microbiol Scand B 83: 103115.
  • Ho YH, Wang LS, Chao HJ, Chang KC & Su CF (2007) Successful treatment of meningitis caused by multidrug-resistant Acinetobacter baumannii with intravenous and intrathecal colistin. J Microbiol Immunol Infect 40: 537540.
  • Huttova M, Freybergh PF, Rudinsky B, Sramka M, Kisac P, Bauer F & Ondrusova A (2007) Postsurgical meningitis caused by Acinetobacter baumannii associated with high mortality. Neuro Endocrinol Lett 28(Suppl 2): 1516.
  • Iacono M, Villa L, Fortini D et al. (2008) Whole-genome pyrosequencing of an epidemic multidrug-resistant Acinetobacter baumannii strain belonging to the European clone II group. Antimicrob Agents Chemother 52: 26162625.
  • Imperi F, Antunes LC, Blom J, Villa L, Iacono M, Visca P & Carattoli A (2011) The genomics of Acinetobacter baumannii: insights into genome plasticity, antimicrobial resistance and pathogenicity. IUBMB Life 63: 10681074.
  • Jacobs AC, Hood I, Boyd KL et al. (2010) Inactivation of phospholipase D diminishes Acinetobacter baumannii pathogenesis. Infect Immun 78: 19521962.
  • Jang TN, Lee SH, Huang CH, Lee CL & Chen WY (2009) Risk factors and impact of nosocomial Acinetobacter baumannii bloodstream infections in the adult intensive care unit: a case-control study. J Hosp Infect 73: 143150.
  • Jawad A, Seifert H, Snelling AM, Heritage J & Hawkey PM (1998) Survival of Acinetobacter baumannii on dry surfaces: comparison of outbreak and sporadic isolates. J Clin Microbiol 36: 19381941.
  • Jin JS, Kwon SO, Moon DC, Gurung M, Lee JH, Kim SI & Lee JC (2011) Acinetobacter baumannii secretes cytotoxic outer membrane protein A via outer membrane vesicles. PLoS ONE 6: e17027.
  • Johnson EN, Burns TC, Hayda RA, Hospenthal DR & Murray CK (2007) Infectious complications of open type III tibial fractures among combat casualties. Clin Infect Dis 45: 409415.
  • Joly-Guillou ML, Wolff M, Pocidalo JJ, Walker F & Carbon C (1997) Use of a new mouse model of Acinetobacter baumannii pneumonia to evaluate the postantibiotic effect of imipenem. Antimicrob Agents Chemother 41: 345351.
  • Joly-Guillou ML, Wolff M, Farinotti R, Bryskier A & Carbon C (2000) In vivo activity of levofloxacin alone or in combination with imipenem or amikacin in a mouse model of Acinetobacter baumannii pneumonia. J Antimicrob Chemother 46: 827830.
  • Jung JY, Park MS, Kim SE et al. (2010) Risk factors for multi-drug resistant Acinetobacter baumannii bacteremia in patients with colonization in the intensive care unit. BMC Infect Dis 10: 228.
  • Katragkou A, Kotsiou M, Antachopoulos C, Benos A, Sofianou D, Tamiolaki M & Roilides E (2006) Acquisition of imipenem-resistant Acinetobacter baumannii in a pediatric intensive care unit: a case-control study. Intensive Care Med 32: 13841391.
  • Keen EF 3rd, Robinson BJ, Hospenthal DR, Aldous WK, Wolf SE, Chung KK & Murray CK (2010a) Prevalence of multidrug-resistant organisms recovered at a military burn center. Burns 36: 819825.
  • Keen EF 3rd, Robinson BJ, Hospenthal DR, Aldous WK, Wolf SE, Chung KK & Murray CK (2010b) Incidence and bacteriology of burn infections at a military burn center. Burns 36: 461468.
  • Kim SW, Choi CH, Moon DC et al. (2009) Serum resistance of Acinetobacter baumannii through the binding of factor H to outer membrane proteins. FEMS Microbiol Lett 301: 224231.
  • Knapp S, Wieland CW, Florquin S et al. (2006) Differential roles of CD14 and toll-like receptors 4 and 2 in murine Acinetobacter pneumonia. Am J Respir Crit Care Med 173: 122129.
  • Ko WC, Lee HC, Chiang SR, Yan JJ, Wu JJ, Lu CL & Chuang YC (2004) In vitro and in vivo activity of meropenem and sulbactam against a multidrug-resistant Acinetobacter baumannii strain. J Antimicrob Chemother 53: 393395.
  • Koomanachai P, Kim A & Nicolau DP (2009) Pharmacodynamic evaluation of tigecycline against Acinetobacter baumannii in a murine pneumonia model. J Antimicrob Chemother 63: 982987.
  • Krol V, Hamid NS & Cunha BA (2009) Neurosurgically related nosocomial Acinetobacter baumannii meningitis: report of two cases and literature review. J Hosp Infect 71: 176180.
  • Kumar SS, Vengadassalapathy L & Menon T (2008) Prosthetic valve endocarditis caused by Acinetobacter baumannii complex. Indian J Pathol Microbiol 51: 573.
  • Kwon SO, Gho YS, Lee JC & Kim SI (2009) Proteome analysis of outer membrane vesicles from a clinical Acinetobacter baumannii isolate. FEMS Microbiol Lett 297: 150156.
  • Lee JC, Koerten H, van den Broek P et al. (2006) Adherence of Acinetobacter baumannii strains to human bronchial epithelial cells. Res Microbiol 157: 360366.
  • Lee NY, Lee HC, Ko NY, Chang CM, Shih HI, Wu CJ & Ko WC (2007) Clinical and economic impact of multidrug resistance in nosocomial Acinetobacter baumannii bacteremia. Infect Control Hosp Epidemiol 28: 713719.
  • Lee HW, Koh YM, Kim J, Lee JC, Lee YC, Seol SY & Cho DT (2008) Capacity of multidrug-resistant clinical isolates of Acinetobacter baumannii to form biofilm and adhere to epithelial cell surfaces. Clin Microbiol Infect 14: 4954.
  • Leung WS, Chu CM, Tsang KY, Lo FH, Lo KF & Ho PL (2006) Fulminant community-acquired Acinetobacter baumannii pneumonia as a distinct clinical syndrome. Chest 129: 102109.
  • Loehfelm TW, Luke NR & Campagnari AA (2008) Identification and characterization of an Acinetobacter baumannii biofilm-associated protein. J Bacteriol 190: 10361044.
  • López-Rojas R, Domínguez-Herrera J, McConnell MJ et al. (2011) Impaired virulence and in vivo fitness of colistin-resistant Acinetobacter baumannii. J Infect Dis 203: 545548.
  • Lowman W, Kalk T, Menezes CN, John MA & Grobusch MP (2008) A case of community-acquired Acinetobacter baumannii meningitis – has the threat moved beyond the hospital? J Med Microbiol 57: 676678.
  • Luke NR, Sauberan SL, Russo TA et al. (2010) Identification and characterization of a glycosyltransferase involved in Acinetobacter baumannii lipopolysaccharide core biosynthesis. Infect Immun 78: 20172023.
  • Lyytikainen O, Koljalg S, Harma M & Vuopio-Varkila J (1995) Outbreak caused by two multi-resistant Acinetobacter baumannii clones in a burns unit: emergence of resistance to imipenem. J Hosp Infect 31: 4154.
  • Maegele M, Gregor S, Steinhausen E et al. (2005) The long-distance tertiary air transfer and care of tsunami victims: injury pattern and microbiological and psychological aspects. Crit Care Med 33: 11361140.
  • Malhotra J, Anand S, Jindal S, Raman R & Lal R (2012) Acinetobacter indicus sp. nov., isolated from hexachlorocyclohexane (HCH) dumpsite. Int J Syst Evol Microbiol in press.
  • Maragakis LL, Cosgrove SE, Song X et al. (2004) An outbreak of multidrug-resistant Acinetobacter baumannii associated with pulsatile lavage wound treatment. JAMA 292: 30063011.
  • Martí S, Rodríguez-Baño J, Catel-Ferreira M, Jouenne T, Vila J, Seifert H & De E (2011) Biofilm formation at the solid-liquid and air-liquid interfaces by Acinetobacter species. BMC Res Notes 4: 5.
  • Mattick JS (2002) Type IV pili and twitching motility. Annu Rev Microbiol 56: 289314.
  • McConnell MJ & Pachón J (2010) Active and passive immunization against Acinetobacter baumannii using an inactivated whole cell vaccine. Vaccine 29: 15.
  • McConnell MJ, Rumbo C, Bou G & Pachón J (2011a) Outer membrane vesicles as an acellular vaccine against Acinetobacter baumannii. Vaccine 29: 57055710.
  • McConnell MJ, Domínguez-Herrera J, Smani Y, López-Rojas R, Docobo-Pérez F & Pachón J (2011b) Vaccination with outer membrane complexes elicits rapid protective immunity to multidrug-resistant Acinetobacter baumannii. Infect Immun 79: 518526.
  • McQueary CN & Actis LA (2011) Acinetobacter baumannii biofilms: variations among strains and correlations with other cell properties. J Microbiol 49: 243250.
  • Menon T, Shanmugasundaram S, Nandhakumar B, Nalina K & Balasubramaniam (2006) Infective endocarditis due to Acinetobacter baumannii complex–a case report. Indian J Pathol Microbiol 49: 576578.
  • Merz AJ, So M & Sheetz MP (2000) Pilus retraction powers bacterial twitching motility. Nature 407: 98102.
  • Metan G, Alp E, Aygen B & Sumerkan B (2007) Acinetobacter baumannii meningitis in post-neurosurgical patients: clinical outcome and impact of carbapenem resistance. J Antimicrob Chemother 60: 197199.
  • Mihara K, Tanabe T, Yamakawa Y, Funahashi T, Nakao H, Narimatsu S & Yamamoto S (2004) Identification and transcriptional organization of a gene cluster involved in biosynthesis and transport of acinetobactin, a siderophore produced by Acinetobacter baumannii ATCC 19606T. Microbiology 150: 25872597.
  • Montero A, Ariza J, Corbella X et al. (2002) Efficacy of colistin versus beta-lactams, aminoglycosides, and rifampin as monotherapy in a mouse model of pneumonia caused by multiresistant Acinetobacter baumannii. Antimicrob Agents Chemother 46: 19461952.
  • Montero A, Ariza J, Corbella X et al. (2004) Antibiotic combinations for serious infections caused by carbapenem-resistant Acinetobacter baumannii in a mouse pneumonia model. J Antimicrob Chemother 54: 10851091.
  • Murray CK, Roop SA, Hospenthal DR et al. (2006) Bacteriology of war wounds at the time of injury. Mil Med 171: 826829.
  • Mussi MA, Gaddy JA, Cabruja M, Viale AM, Rasia R & Actis LA (2010) Motility, virulence and biofilm formation by the human pathogen Acinetobacter baumannii are affected by blue light. J Bacteriol 192: 63366345.
  • Neely AN (2000) A survey of gram-negative bacteria survival on hospital fabrics and plastics. J Burn Care Rehabil 21: 523527.
  • Neely AN, Maley MP & Warden GD (1999) Computer keyboards as reservoirs for Acinetobacter baumannii in a burn hospital. Clin Infect Dis 29: 13581360.
  • Nemec A, Krizova L, Maixnerova M et al. (2011) Genotypic and phenotypic characterization of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex with the proposal of Acinetobacter pittii sp. nov. (formerly Acinetobacter genomic species 3) and Acinetobacter nosocomialis sp. nov. (formerly Acinetobacter genomic species 13TU). Res Microbiol 162: 393404.
  • Ng J, Gosbell IB, Kelly JA, Boyle MJ & Ferguson JK (2006) Cure of multiresistant Acinetobacter baumannii central nervous system infections with intraventricular or intrathecal colistin: case series and literature review. J Antimicrob Chemother 58: 10781081.
  • Niu C, Clemmer KM, Bonomo RA & Rather PN (2008) Isolation and characterization of an autoinducer synthase from Acinetobacter baumannii. J Bacteriol 190: 33863392.
  • Olitzki L (1948) Mucin as a resistance-lowering substance. Bacteriol Rev 12: 149172.
  • Olut AI & Erkek E (2005) Early prosthetic valve endocarditis due to Acinetobacter baumannii: a case report and brief review of the literature. Scand J Infect Dis 37: 919921.
  • Ozaki T, Nishimura N, Arakawa Y et al. (2009) Community-acquired Acinetobacter baumannii meningitis in a previously healthy 14-month-old boy. J Infect Chemother 15: 322324.
  • Pachón-Ibañez ME, Fernández-Cuenca F, Docobo-Pérez F, Pachón J & Pascual A (2006) Prevention of rifampicin resistance in Acinetobacter baumannii in an experimental pneumonia murine model, using rifampicin associated with imipenem or sulbactam. J Antimicrob Chemother 58: 689692.
  • Pachón-Ibañez ME, Docobo-Pérez F, López-Rojas R et al. (2010) Efficacy of rifampin and its combinations with imipenem, sulbactam, and colistin in experimental models of infection caused by imipenem-resistant Acinetobacter baumannii. Antimicrob Agents Chemother 54: 11651172.
  • Pantopoulou A, Giamarellos-Bourboulis EJ, Raftogannis M et al. (2007) Colistin offers prolonged survival in experimental infection by multidrug-resistant Acinetobacter baumannii: the significance of co-administration of rifampicin. Int J Antimicrob Agents 29: 5155.
  • Paramythiotou E, Karakitsos D, Aggelopoulou H, Sioutos P, Samonis G & Karabinis A (2007) Post-surgical meningitis due to multiresistant Acinetobacter baumannii. Effective treatment with intravenous and/or intraventricular colistin and therapeutic dilemmas. Med Mal Infect 37: 124125.
  • Peleg AY, Seifert H & Paterson DL (2008a) Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 21: 538582.
  • Peleg AY, Tampakakis E, Fuchs BB, Eliopoulos GM, Moellering RC Jr & Mylonakis E (2008b) Prokaryote-eukaryote interactions identified by using Caenorhabditis elegans. P Natl Acad Sci USA 105: 1458514590.
  • Peleg AY, Jara S, Monga D, Eliopoulos GM, Moellering RC Jr & Mylonakis E (2009) Galleria mellonella as a model system to study Acinetobacter baumannii pathogenesis and therapeutics. Antimicrob Agents Chemother 53: 26052609.
  • Perlman BB & Freedman LR (1971) Experimental endocarditis. II. Staphylococcal infection of the aortic valve following placement of a polyethylene catheter in the left side of the heart. Yale J Biol Med 44: 206213.
  • Pichardo C, Pachón-Ibañez ME, Docobo-Pérez F, López-Rojas R, Jiménez-Mejias ME, Garcia-Curiel A & Pachón J (2010) Efficacy of tigecycline vs. imipenem in the treatment of experimental Acinetobacter baumannii murine pneumonia. Eur J Clin Microbiol Infect Dis 29: 527531.
  • Qiu H, KuoLee R, Harris G & Chen W (2009a) High susceptibility to respiratory Acinetobacter baumannii infection in A/J mice is associated with a delay in early pulmonary recruitment of neutrophils. Microbes Infect 11: 946955.
  • Qiu H, Kuolee R, Harris G & Chen W (2009b) Role of NADPH phagocyte oxidase in host defense against acute respiratory Acinetobacter baumannii infection in mice. Infect Immun 77: 10151021.
  • Rao RS, Karthika RU, Singh SP, Shashikala P, Kanungo R, Jayachandran S & Prashanth K (2008) Correlation between biofilm production and multiple drug resistance in imipenem resistant clinical isolates of Acinetobacter baumannii. Indian J Med Microbiol 26: 333337.
  • Roberts SA, Findlay R & Lang SD (2001) Investigation of an outbreak of multi-drug resistant Acinetobacter baumannii in an intensive care burns unit. J Hosp Infect 48: 228232.
  • Rodríguez Guardado A, Blanco A, Asensi V et al. (2008) Multidrug-resistant Acinetobacter meningitis in neurosurgical patients with intraventricular catheters: assessment of different treatments. J Antimicrob Chemother 61: 908913.
  • Rodríguez-Baño J, Cisneros JM, Fernández-Cuenca F et al. (2004) Clinical features and epidemiology of Acinetobacter baumannii colonization and infection in Spanish hospitals. Infect Control Hosp Epidemiol 25: 819824.
  • Rodríguez-Baño J, García L, Ramírez E et al. (2009) Long-term control of hospital-wide, endemic multidrug-resistant Acinetobacter baumannii through a comprehensive “bundle” approach. Am J Infect Control 37: 715722.
  • Rodríguez-Hernández MJ, Pachón J, Pichardo C et al. (2000) Imipenem, doxycycline and amikacin in monotherapy and in combination in Acinetobacter baumannii experimental pneumonia. J Antimicrob Chemother 45: 493501.
  • Rodríguez-Hernández MJ, Cuberos L, Pichardo C et al. (2001) Sulbactam efficacy in experimental models caused by susceptible and intermediate Acinetobacter baumannii strains. J Antimicrob Chemother 47: 479482.
  • Rodríguez-Hernández MJ, Jiménez-Mejias ME, Pichardo C, Cuberos L, Garcia-Curiel A & Pachón J (2004) Colistin efficacy in an experimental model of Acinetobacter baumannii endocarditis. Clin Microbiol Infect 10: 581584.
  • Rumbo C, Fernández-Moreira E, Merino M et al. (2011) Horizontal transfer of the OXA-24 carbapenemase gene via outer membrane vesicles: a new mechanism of dissemination of carbapenem resistance genes in Acinetobacter baumannii. Antimicrob Agents Chemother 55: 30843090.
  • Russo TA, Beanan JM, Olson R, MacDonald U, Luke NR, Gill SR & Campagnari AA (2008) Rat pneumonia and soft-tissue infection models for the study of Acinetobacter baumannii biology. Infect Immun 76: 35773586.
  • Russo TA, MacDonald U, Beanan JM et al. (2009) Penicillin-binding protein 7/8 contributes to the survival of Acinetobacter baumannii in vitro and in vivo. J Infect Dis 199: 513521.
  • Russo TA, Luke NR, Beanan JM et al. (2011) The K1 capsular polysaccharide of Acinetobacter baumannii strain 307-0294 is a major virulence factor. Infect Immun 78: 39934000.
  • Sacar S, Turgut H, Cenger DH, Coskun E, Asan A & Kaleli I (2007) Successful treatment of multidrug resistant Acinetobacter baumannii meningitis. J Infect Dev Ctries 1: 342344.
  • Sader HS, Jones RN & Silva JB (2002) Skin and soft tissue infections in Latin American medical centers: four-year assessment of the pathogen frequency and antimicrobial susceptibility patterns. Diagn Microbiol Infect Dis 44: 281288.
  • Salmanian AH, Siavoshi F, Akbari F, Afshari A & Malekzadeh R (2008) Yeast of the oral cavity is the reservoir of Heliobacter pylori. J Oral Pathol Med 37: 324328.
  • Sauvage E, Kerff F, Terrak M, Ayala JA & Charlier P (2008) The penicillin-binding proteins: structure and role in peptidoglycan biosynthesis. FEMS Microbiol Rev 32: 234258.
  • Schafer JJ & Mangino JE (2008) Multidrug-resistant Acinetobacter baumannii osteomyelitis from Iraq. Emerg Infect Dis 14: 512514.
  • Scott P, Deye G, Srinivasan A et al. (2007) An outbreak of multidrug-resistant Acinetobacter baumannii-calcoaceticus complex infection in the US military health care system associated with military operations in Iraq. Clin Infect Dis 44: 15771584.
  • Sebeny PJ, Riddle MS & Petersen K (2008) Acinetobacter baumannii skin and soft-tissue infection associated with war trauma. Clin Infect Dis 47: 444449.
  • Seifert H, Strate A & Pulverer G (1995) Nosocomial bacteremia due to Acinetobacter baumannii. Clinical features, epidemiology, and predictors of mortality. Medicine (Baltimore) 74: 340349.
  • Sengstock DM, Thyagarajan R, Apalara J, Mira A, Chopra T & Kaye KS (2010) Multidrug-resistant Acinetobacter baumannii: an emerging pathogen among older adults in community hospitals and nursing homes. Clin Infect Dis 50: 16111616.
  • Shankar R, He LK, Szilagyi A et al. (2007) A novel antibacterial gene transfer treatment for multidrug-resistant Acinetobacter baumannii-induced burn sepsis. J Burn Care Res 28: 612.
  • Siegman-Igra Y, Bar-Yosef S, Gorea A & Avram J (1993) Nosocomial acinetobacter meningitis secondary to invasive procedures: report of 25 cases and review. Clin Infect Dis 17: 843849.
  • Smani Y, López-Rojas R, Domínguez-Herrera J, Docobo-Pérez F, Marti S, Vila J & Pachón J (2012) In vitro and in vivo reduced fitness and virulence in ciprofloxacin-resistant Acinetobacter baumannii. Clin Microbiol Infect 18: E1E4.
  • Smith MG, Des Etages SG & Snyder M (2004) Microbial synergy via an ethanol-triggered pathway. Mol Cell Biol 24: 38743884.
  • Smith MG, Gianoulis TA, Pukatzki S, Mekalanos JJ, Ornston LN, Gerstein M & Snyder M (2007) New insights into Acinetobacter baumannii pathogenesis revealed by high-density pyrosequencing and transposon mutagenesis. Genes Dev 21: 601614.
  • Snitkin ES, Zelazny AM, Montero CI, Stock F, Mijares L, Murray PR & Segre JA (2011) Genome-wide recombination drives diversification of epidemic strains of Acinetobacter baumannii. P Natl Acad Sci USA 108: 1375813763.
  • Song JY, Cheong HJ, Lee J, Sung AK & Kim WJ (2009) Efficacy of monotherapy and combined antibiotic therapy for carbapenem-resistant Acinetobacter baumannii pneumonia in an immunosuppressed mouse model. Int J Antimicrob Agents 33: 3339.
  • Stanley NR & Lazazzera BA (2004) Environmental signals and regulatory pathways that influence biofilm formation. Mol Microbiol 52: 917924.
  • Taccone FS, Rodríguez-Villalobos H, De Backer D, De Moor V, Deviere J, Vincent JL & Jacobs F (2006) Successful treatment of septic shock due to pan-resistant Acinetobacter baumannii using combined antimicrobial therapy including tigecycline. Eur J Clin Microbiol Infect Dis 25: 257260.
  • Taziarova M, Holeckova K, Lesnakova A et al. (2007) Gram-negative bacillary community acquired meningitis is not a rare entity in last two decades. Neuro Endocrinol Lett 28(Suppl 3): 1819.
  • Thomas-Virnig CL, Centanni JM, Johnston CE et al. (2009) Inhibition of multidrug-resistant Acinetobacter baumannii by nonviral expression of hCAP-18 in a bioengineered human skin tissue. Mol Ther 17: 562569.
  • Tomaras AP, Dorsey CW, Edelmann RE & Actis LA (2003) Attachment to and biofilm formation on abiotic surfaces by Acinetobacter baumannii: involvement of a novel chaperone-usher pili assembly system. Microbiology 149: 34733484.
  • Tomaras AP, Flagler MJ, Dorsey CW, Gaddy JA & Actis LA (2008) Characterization of a two-component regulatory system from Acinetobacter baumannii that controls biofilm formation and cellular morphology. Microbiology 154: 33983409.
  • Towner KJ (2009) Acinetobacter: an old friend, but a new enemy. J Hosp Infect 73: 355363.
  • Trottier V, Segura PG, Namias N, King D, Pizano LR & Schulman CI (2007) Outcomes of Acinetobacter baumannii infection in critically ill burned patients. J Burn Care Res 28: 248254.
  • Uygur F, Oncul O, Evinc R, Diktas H, Acar A & Ulkur E (2009) Effects of three different topical antibacterial dressings on Acinetobacter baumannii-contaminated full-thickness burns in rats. Burns 35: 270273.
  • Valencia R, Arroyo LA, Conde M et al. (2009) Nosocomial outbreak of infection with pan-drug-resistant Acinetobacter baumannii in a tertiary care university hospital. Infect Control Hosp Epidemiol 30: 257263.
  • van Faassen H, KuoLee R, Harris G, Zhao X, Conlan JW & Chen W (2007) Neutrophils play an important role in host resistance to respiratory infection with Acinetobacter baumannii in mice. Infect Immun 75: 55975608.
  • Vila J & Pachón J (2008) Therapeutic options for Acinetobacter baumannii infections. Expert Opin Pharmacother 9: 587599.
  • Villegas MV & Hartstein AI (2003) Acinetobacter outbreaks, 1977–2000. Infect Control Hosp Epidemiol 24: 284295.
  • Wandersman C & Delepelaire P (2004) Bacterial iron sources: from siderophores to hemophores. Annu Rev Microbiol 58: 611647.
  • Wareham DW, Bean DC, Khanna P, Hennessy EM, Krahe D, Ely A & Millar M (2008) Bloodstream infection due to Acinetobacter spp: epidemiology, risk factors and impact of multi-drug resistance. Eur J Clin Microbiol Infect Dis 27: 607612.
  • Weinberg ED (2009) Iron availability and infection. Biochim Biophys Acta 1790: 600605.
  • Wendt C, Dietze B, Dietz E & Ruden H (1997) Survival of Acinetobacter baumannii on dry surfaces. J Clin Microbiol 35: 13941397.
  • Wisplinghoff H, Perbix W & Seifert H (1999) Risk factors for nosocomial bloodstream infections due to Acinetobacter baumannii: a case-control study of adult burn patients. Clin Infect Dis 28: 5966.
  • Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP & Edmond MB (2004) Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 39: 309317.
  • Wolff M, Joly-Guillou ML, Farinotti R & Carbon C (1999) In vivo efficacies of combinations of beta-lactams, beta-lactamase inhibitors, and rifampin against Acinetobacter baumannii in a mouse pneumonia model. Antimicrob Agents Chemother 43: 14061411.
  • Yamamoto S, Okujo N & Sakakibara Y (1994) Isolation and structure elucidation of acinetobactin, a novel siderophore from Acinetobacter baumannii. Arch Microbiol 162: 249252.
  • Yamamoto S, Okujo N, Kataoka H & Narimatsu S (1999) Siderophore-mediated utilization of transferrin- and lactoferrin-bound iron by Acinetobacter baumannii. J Health Sci 45: 297302.
  • Yuan Z, Ledesma KR, Singh R, Hou J, Prince RA & Tam VH (2010) Quantitative assessment of combination antimicrobial therapy against multidrug-resistant bacteria in a murine pneumonia model. J Infect Dis 201: 889897.
  • Zimbler DL, Penwell WF, Gaddy JA, Menke SM, Tomaras AP, Connerly PL & Actis LA (2009) Iron acquisition functions expressed by the human pathogen Acinetobacter baumannii. Biometals 22: 2332.